During the past decade, Hospital Universitari I Politecnic La Fe conducted 776 clinical trials. In the 10-year time frame, 776 clinical trials started and 245 clinical trials were completed, i.e. on average, 31.6% percent of trials that started reached the finish line to date. In the past 5 years, 377 clinical trials started and 187 clinical trials were completed. i.e. 49.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Universitari I Politecnic La Fe" #1 sponsor was "PETHEMA Foundation" with 66 trials, followed by "Hoffmann-La Roche" with 54 trials sponsored, "Pfizer" with 43 trials sponsored, "Celgene" with 41 trials sponsored and "Janssen Research & Development, LLC" with 41 trials sponsored. Other sponsors include 817 different institutions and companies that sponsored additional 368 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Universitari I Politecnic La Fe" #1 collaborator was "Hospital Universitario La Fe" with 14 trials as a collaborator, "Merck Sharp & Dohme LLC" with 14 trials as a collaborator, "Pfizer" with 12 trials as a collaborator, "Bristol-Myers Squibb" with 10 trials as a collaborator and "Hoffmann-La Roche" with 10 trials as a collaborator. Other collaborators include 530 different institutions and companies that were collaborators in the rest 383 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Universitari I Politecnic La Fe" are "Multiple Myeloma" (39 trials), "Acute Myeloid Leukemia" (34 trials), "Myelodysplastic Syndromes" (22 trials), "Breast Cancer" (16 trials) and "Carcinoma, Non-Small-Cell Lung" (16 trials). Many other conditions were trialed in "Hospital Universitari I Politecnic La Fe" in a lesser frequency.

Most popular intervention types in "Hospital Universitari I Politecnic La Fe" are "Drug" (775 trials), "Other" (97 trials), "Biological" (66 trials), "Device" (58 trials) and "Procedure" (55 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (191 trials), "Dexamethasone" (31 trials), "Carboplatin" (25 trials), "Atezolizumab" (24 trials) and "Cisplatin" (21 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Universitari I Politecnic La Fe" are 941 trials for "All" genders, 70 trials for "Female" genders and 41 trials for "Male" genders.

Currently, there are 403 active trials in "Hospital Universitari I Politecnic La Fe". 4 are not yet recruiting, 234 are recruiting, 158 are Active, not recruiting, and 7 are Enrolling by invitation. In total, there were 483 completed trials in Hospital Universitari I Politecnic La Fe, undefined suspended trials, and 102 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Universitari I Politecnic La Fe, 92 "Phase 1" clinical trials were conducted, 317 "Phase 2" clinical trials and 395 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 80 trials, and there were also 67 trials that are defined as “Not Applicable".